metasteses
Showing 1 - 8 of 8
Bone Metastases Trial in Baltimore (radiosurgical hypophysectomy)
Recruiting
- Bone Metastases
- radiosurgical hypophysectomy
-
Baltimore, MarylandThe Sidney Kimmel Comprehsensive Cancer Center at Johns Hopkins
Sep 17, 2021
Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant
Withdrawn
- Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
- +3 more
- Abemaciclib
- +3 more
- (no location specified)
Oct 13, 2021
COPD Trial in Worldwide (BGF MDI 320/14.4/9.6 µg, GFF MDI (PT003) 14.4/9.6 µg, BFF MDI (PT009) 320/9.6 µg)
Completed
- COPD
- BGF MDI 320/14.4/9.6 μg
- +3 more
-
Andalusia, Alabama
- +189 more
Dec 23, 2020
Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)
Completed
- Triple Negative Breast Cancer
- +3 more
-
Boston, Massachusetts
- +19 more
Jul 12, 2021
Coronary Heart Disease Trial in Worldwide (Dalcetrapib (RO4607381), Evidence-based medical care for Acute Coronary Syndrome,
Completed
- Coronary Heart Disease
- Dalcetrapib (RO4607381)
- +2 more
-
Birmingham, Alabama
- +1090 more
Dec 16, 2019
Tumor Metastasis, Sarcoma, Tumors, Germ Cell and Embryonal Trial (decitabine (DAC), Tetrahydrouridine (THU), Celecoxib)
Withdrawn
- Neoplasm Metastasis
- +3 more
- decitabine (DAC)
- +2 more
- (no location specified)
Jul 3, 2018
Metastatic Colorectal Cancer Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin,
Completed
- Metastatic Colorectal Cancer
- Sorafenib (Nexavar, BAY43-9006) + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
- Matching placebo + mFOLFOX6 (5-FU, levo-leucovorin, oxaliplatin)
-
Wichita, Kansas
- +115 more
Nov 25, 2014